ACQUISITION OF PHARMACEUTICAL PRODUCTS - CORPORATE PURCHASE FOR SUPPLY OVER A TWELVE (12) MONTH PERIOD - TABLETS (22 ITEMS)

The National Center for the Procurement of Strategic Health Resources (CENARES) of the Ministry of Health (MINSA) in Lima, Peru, is issuing a tender for the acquisition of pharmaceutical products. This is a corporate purchase aimed at ensuring the supply of specific items over a twelve-month period. The tender specifically focuses on the procurement of tablets, with a list of 22 distinct items included in the scope of work. The procurement method to be employed is Electronic Reverse Auction (Subasta Inversa Electrónica), identified under the process number SIE-SIE-45-2025-CENARES/MINSA-1. This process is designed to achieve competitive pricing through an online auction format where suppliers bid down their prices. Interested parties are invited to participate in this electronic reverse auction to supply the required pharmaceutical tablets. The objective is to secure a reliable and cost-effective supply chain for essential medicines for the health sector in Lima. Further details regarding the specific technical specifications for each of the 22 tablet items, eligibility criteria for bidders, and the auction timeline will be made available through the official procurement platform associated with this tender. CENARES seeks to engage qualified pharmaceutical suppliers capable of meeting the demand and quality standards required for public health services.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 14.3 million.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.